Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database

• Główni autorzy: Ali F. Altebainawi (Autor), Lulwa A. Alfaraj (Autor), Amjad A. Alharbi (Autor), Fadwa F. Alkhuraisi (Autor), Thamir M. Alshammari (Autor)
• Format: Książka
• Wydane: SAGE Publishing, 2023-02-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Background: This research aims to explore and compare the signals of rhabdomyolysis from the use of Proton pump inhibitors (PPIs) using the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database. Methods: Rhabdomyolysis and related terms submitted between 2013 and...